Research and Development
Nice backs GSK’s lupus drug Benlysta
May 11, 2016 Research and Development, Sales and Marketing GSK, NHS, NICE, regulation
Gilead’s Sovaldi gets Indian patent; critics call it “major blow” to patient access
May 11, 2016 Manufacturing and Production, Research and Development, Sales and Marketing India, harm, hepatitis, patent, patient access, sovaldi
Santen Pharmaceutical says eye allergy drug meets primary endpoints in Phase III trials
May 11, 2016 Research and Development, Sales and Marketing Eye Allergy, Santen Pharmaceutical, drug trial, phase III
Allergan to buy back $10 billion of stock, Q1 earnings rise
May 11, 2016 Research and Development, Sales and Marketing Allergan, Buy Back, Financial, Q1, earnings, results, revenue
FDA expands Imbruvica label with new survival data
May 11, 2016 Research and Development, Sales and Marketing AbbVie, FDA, Janssen, data, efficacy, expanded, imbruvica, label, late stage, phase III
Baxalta sues Chugai for haemophilia drug patent breach
May 11, 2016 Research and Development Baxalta, Chugai, breach, court, haemophilia, infringe, infringement, patent, sue, suing
Incyte acquires Ariad’s European operations in $140 million deal
May 10, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Ariad, Incyte, Operations, buy out, european, iclusig, leukaemia, out-license
Cell Therapy signs £12.5 million licensing deal with Daiichi Sankyo for heart failure treatment
May 10, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Daiichi Sankyo, Deals, cell therapy, heart failure, licensing
Medivation maybe mulling sale as bidding race heats up – Reports
May 10, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Deals, M&A, MA, Medivation, Pfizer, Sanofi
Takeda secures $38 million grant to develop affordable polio vaccine
May 10, 2016 Manufacturing and Production, Research and Development Bill and Melinda Gates Foundation, Gates Foundation, Takeda, Vaccine, access, developing countries, grant, polio
Scottish Medicines Consortium does not back Vertex’ cystic fibrosis drugs Orkambi, Kalydeco
May 10, 2016 Manufacturing and Production, Research and Development Kalydeco, Orkambi, SMC, Vertex Pharma, cystic fibrosis, regulation
Second child cleared of leukaemia after Cellectis T-cell treatment
May 10, 2016 Manufacturing and Production, Research and Development cellecits, childhood, children, designer cells, leukaemia, rare, t cells, t-cells
China evaluating investigations into pharma firms to take on drug pricing issue
May 9, 2016 Business Services, Research and Development, Sales and Marketing China, France, G7, regulation
UK pharma would benefit by remaining in EU, says ABPI
May 9, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Andrew Witty, EU, brexit, letter, observer, pascal soriot, remain, stay
Focus: Governments evaluate policies, reforms as drug pricing debate rages on
May 9, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
